Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 979702, 8 pages
http://dx.doi.org/10.1155/2013/979702
Research Article

Notch Signaling Molecules Activate TGF-β in Rat Mesangial Cells under High Glucose Conditions

1Department of Endocrinology, The Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan, China
2Department of Endocrinology, The People's Hospital of Yongchuan, Yongchuan, Chongqing, China
3Department of Endocrinology, The First Hospital of Yibin, Yibin, Sichuan, China

Received 27 November 2012; Revised 17 March 2013; Accepted 31 March 2013

Academic Editor: Aimin Xu

Copyright © 2013 Li Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Niranjan, B. Bielesz, A. Gruenwald et al., “The Notch pathway in podocytes plays a role in the development of glomerular disease,” Nature Medicine, vol. 14, no. 3, pp. 290–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Barisoni, H. W. Schnaper, and J. B. Kopp, “A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 529–542, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. T. Teachey, A. E. Seif, V. I. Brown et al., “Targeting Notch signaling in autoimmune and lymphoproliferative disease,” Blood, vol. 111, no. 2, pp. 705–714, 2008. View at Google Scholar
  4. J. H. Li, X. L. Qu, and J. F. Bertram, “Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice,” The American Journal of Pathology, vol. 175, no. 4, pp. 1380–1388, 2009. View at Google Scholar
  5. D. W. Walsh, S. A. Roxburgh, P. McGettigan et al., “Co-regulation of Gremlin and Notch signalling in diabetic nephropathy,” Biochim Biophys Acta, vol. 1782, no. 1, pp. 10–21, 2008. View at Google Scholar
  6. F. P. Schena and L. Gesualdo, “Pathogenetic mechanisms of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 16, supplement 1, pp. S30–S33, 2005. View at Google Scholar
  7. J. Morrissey, G. Guo, K. Moridaira et al., “Transforming growth factor-β beta induces renal epithelial Jagged-l expression in fibrotic disease,” Journal of the American Society of Nephrology, vol. 13, no. 6, pp. 1499–1508, 2002. View at Google Scholar
  8. R. Kopan and M. X. G. Ilagan, “The canonical Notch signaling pathway: unfolding the activation mechanism,” Cell, vol. 137, no. 2, pp. 216–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. X. Ilagan and R. Kopan, “SnapShot: Notch signaling pathway,” Cell, vol. 128, no. 6, article 1246, 2007. View at Google Scholar
  10. M. Baron, “An overview of the Notch signall-ing pathway,” Seminars in Cell & Developmental Biology, vol. 14, no. 2, pp. 113–119, 2003. View at Google Scholar
  11. M. Murea, J. K. Park, S. Sharma et al., “Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function,” Kidney International, vol. 78, no. 5, pp. 514–522, 2010. View at Google Scholar
  12. A. L. Penton, L. Leonard, and N. Spinner, “Notch signaling in human development and disease,” Seminars in Cell & Developmental Biology, vol. 23, no. 4, pp. 450–457, 2012. View at Google Scholar
  13. M. Baron, H. Aslam, M. Flasza et al., “Multiple levels of Notch signal regulation,” Molecular Membrane Biology, vol. 19, no. 1, pp. 27–38, 2002. View at Google Scholar
  14. Y. Sirin and K. Susztak, “Notch in the kidney: development and disease,” The Journal of Pathology, vol. 226, no. 2, pp. 394–403, 2012. View at Google Scholar
  15. E. C. Lai, “Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins,” EMBO Reports, vol. 3, no. 9, pp. 840–845, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Wu, T. Sun, K. Kobayashi et al., “Identifi- cation of a family of mastermind-like transcriptional coactivators for mammalian notch receptors,” Molecular and Cellular Biology, vol. 22, no. 21, pp. 7688–7700, 2002. View at Google Scholar
  17. S. Sumual, S. Saad, O. Tang et al., “Differential regulation of Snail by hypoxia and hyperglycemia in human proximal tubule cells,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 10, pp. 1689–1697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. L. Lin, F. S. Wang, Y. C. Hsu et al., “Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy,” Diabetes, vol. 59, no. 8, pp. 1915–1925, 2010. View at Google Scholar
  19. T. Niranjan, M. Murea, and K. Susztak, “The pathogenic role of notch activation in podocytes,” Nephron, vol. 111, no. 4, pp. e73–e79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Bielesz, Y. Sirin, H. Si et al., “Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans,” Journal of Clinical Investigation, vol. 120, no. 11, pp. 4040–4054, 2010. View at Google Scholar
  21. D. JaVelaud and A. Mauviel, “Transforming growth factor-betas:smad signaling and roles in physiopathology,” Pathologie Biologie, vol. 52, no. 1, pp. 50–54, 2004. View at Google Scholar
  22. B. Pasche, “Role of transforming growth factor beta in cancer,” Journal of Cellular Physiology, vol. l86, no. 2, pp. 53–168, 200l. View at Google Scholar
  23. K. C. Nyhan, N. Faherty, G. Murray et al., “Jagged/Notch signalling is required for a subset of TGFβ1 responses in human kidney epithelial cells,” Biochimica et Biophysica Acta, vol. 1803, no. 12, pp. 1386–1395, 2010. View at Google Scholar
  24. W. Wang, V. Koka, and H. Y. lan, “Transforming growth factor-beta and smad signalling in kidney diseases,” Nephrology, vol. 10, no. 1, pp. 48–56, 2005. View at Google Scholar
  25. M. Fujimoto, Y. Maezawa, K. Yokote et al., “Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy,” Biochemical and Biophysical Research Communications, vol. 305, no. 4, pp. 1002–1007, 2003. View at Google Scholar
  26. Y. Li, J. Yang, C. Dai et al., “Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis,” The Journal of Clinical Investigation, vol. 112, no. 4, pp. 503–516, 2003. View at Google Scholar
  27. P. R. Mertens, U. Raffetseder, and T. Rauen, “Notch receptors: a new target in glomerular diseases,” Nephrology Dialysis Transplantation, vol. 23, no. 9, pp. 2743–2745, 2008. View at Google Scholar
  28. J. Zavadil, L. Cermak, N. Soto-Nieves et al., “Integration of TGF-beta/Smad and Jaggedl/Notch signalling in epithelial-to-mesenchymal transition,” EMBO Journal, vol. 23, no. 5, pp. 1155–1165, 2004. View at Google Scholar